IMRN · Immuron Ltd
Market Cap
$9.40M
Shares
8.07M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$1.11
Open$1.15
Day$1.11–1.17
52W close$0.70–2.35
Avg vol 30d17K
Short int40K · 0.5% float · 2.3d
Short vol57%
Last earningsJun 30, 2022
DataJan 2020–Sep 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
—
Year over year · more shares
Price change (1Y)
-40.3%
Trailing year
Short interest
0.5%
Latest settlement · 2.3 days to cover
Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Neutral
Momentum
Very Strong
Sentiment
Bearish
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 14.3 · calm
Equity put/call 0.47
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+8%
above
Price vs 50-day avg
−2%
below
RSI (14)
48
neutral
MACD trend
Negative
52-week position
25%
mid-range
Momentum
relative strength
1-month return
+1%
trailing
6-month return
+42%
trailing
YTD return
+45%
this year
Relative strength
+25%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $1 › 200d $1 — 50d above 200d
Institutional flow
Distributing
-14% holders QoQ · +2 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.49% of float · ▲ +10.3% MoM · 2.3 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
6 holders — mid 3-yr range
Squeeze score
42
elevated · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
89%
annualized · 1-yr
Max drawdown
−70%
past year
ATR
6.3%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+8%
Bullish
Price vs 50-day avg
−2%
Neutral
RSI (14)
48
Neutral
MACD trend
Negative
Bearish
52-week position
25%
Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross)
No cross
50d $1 › 200d $1 — 50d above 200d
Institutional flow
Distributing
-14% holders QoQ · +2 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.49% of float · ▲ +10.3% MoM · 2.3 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
6 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $1
Now $1 · 25%
Range high $2
vs 200-day avg +8%
vs 50-day avg -2%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
IMRN
this stock
Immuron Ltd
|
$9.40M | +45.5% | — | — | 0.5% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$141.42B | +23.1% | +46.2% | 32.5 | 1.6% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$86.84B | +9.3% | +20.8% | 20.9 | 2.3% |
|
ARGX
Argenx SE
|
$64.44B | +25.3% | — | — | 1.9% |
|
CSLLY
Csl Ltd
|
$59.96B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Reducing
Holders
6
- % held
- 1.0%
- Net QoQ
- -6.5K sh
- Top holder
- CITADEL ADVISORS LLC
Held
Float
Short & Settlement
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| IMRN | -4.7% | +0.9% | +41.8% | +0.0% | +45.5% |
| SPY | +0.3% | +0.6% | +16.7% | +0.8% | +13.4% |
| vs SPY | -5.0% | +0.3% | +25.0% | -0.8% | +32.1% |